Strategic Education
STRA
80.68
+0.86
+1.08%
Strategic Education
US · STRA
#2878 by market cap
Listed 1970
80.68
+0.86
+1.08%
Live - 5344 symbols - heartbeat 452s ago
· 2026-10-07 19:54
After-hours
80.68
0.00%
- Market cap
- 1.79B
- P/E (TTM)i
- 13.47
- P/Bi
- 1.10
- EPSi
- 5.41
- Div yieldi
- 2.97%
- 52W posi
- 59%
Reader sentiment
Are you bullish or bearish on STRA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.89, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +3.96% YoY
Margins
- Gross margin
- 48.97%
- Operating margin
- 15.47%
- Net margin
- 9.98%
Key ratios & quality
- PEG ratioi
- 0.34
- Altman Z-Scorei
- 3.89
PEG uses trailing P/E against the 3-year net income growth rate (39.47%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 634.19M | 997.14M | 1.03B | 1.13B | 1.07B | 1.13B | 1.22B | 1.27B |
| Gross profit | 262.64M | 466.53M | 494.99M | 523.43M | 468.16M | 509.02M | 569.43M | 621.11M |
| Selling & admin expenses | 194.04M | 272.41M | 295.23M | 361.35M | 379.82M | 384.44M | 412.16M | 424.97M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 42.91M | 132.46M | 135.54M | 110.59M | 73.99M | 113.12M | 157.28M | 196.14M |
| Pretax profit | -19.14M | 123.72M | 113.96M | 76.60M | 69.57M | 100.73M | 161.43M | 177.39M |
| Tax | -3.47M | 42.59M | 27.69M | 21.51M | 22.90M | 30.94M | 48.75M | 50.78M |
| Net profit | -15.67M | 81.14M | 86.27M | 55.09M | 46.67M | 69.79M | 112.68M | 126.61M |
| Basic EPS | -1 | 4 | 4 | 2 | 2 | 3 | 5 | 6 |
| Diluted EPS | -1.03 | 3.67 | 3.77 | 2.28 | 1.94 | 2.91 | 4.67 | 5.41 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 303.59M | 321.47M | 319.95M | 323.21M | 305.93M | 337.26M |
| Gross profit | 145.30M | 155.32M | 157.23M | 163.26M | 151.16M | 159.39M |
| Selling & admin expenses | 103.60M | 106.78M | 105.93M | 108.67M | 107.97M | 106.45M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 41.71M | 48.54M | 51.29M | 54.60M | 43.19M | 52.95M |
| Pretax profit | 42.01M | 45.45M | 36.77M | 53.17M | 42.29M | 51.83M |
| Tax | 12.26M | 13.11M | 10.14M | 15.27M | 9.48M | 14.67M |
| Net profit | 29.74M | 32.33M | 26.63M | 37.91M | 32.81M | 37.16M |
| Basic EPS | 1 | 1 | 1 | 2 | 2 | 2 |
| Diluted EPS | 1.24 | 1.37 | 1.15 | 1.66 | 1.48 | 1.71 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 420.36M | 524.09M | 286.12M | 367.79M | 329.06M | 329.07M | 304.94M | 277.86M |
| Cash & ST investments | 348.85M | 454.57M | 195.07M | 275.42M | 222.82M | 208.21M | 184.02M | 148.05M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 1.66B | 1.79B | 2.30B | 2.31B | 2.16B | 2.13B | 2.05B | 2.04B |
| Total current liabilities | 125.13M | 156.75M | 200.05M | 195.76M | 209.94M | 209.62M | 216.46M | 217.94M |
| Short-term debt | -- | 25.28M | 34.81M | 27.01M | 23.88M | 24.19M | 22.22M | 15.91M |
| Long-term debt | -- | -- | 141.82M | 141.63M | 101.40M | 61.40M | -- | -- |
| Total liabilities | 235,805,000.00 | 326,698,000.00 | 547,488,000.00 | 591,890,000.00 | 525,957,000.00 | 472,695,000.00 | 387,236,000.00 | 392,134,000.00 |
| Total equity | 1.43B | 1.46B | 1.75B | 1.71B | 1.64B | 1.65B | 1.66B | 1.65B |
| Retained earnings | 118.32M | 152.82M | 179.65M | 174.57M | 159.69M | 168.87M | 218.41M | 255.50M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 328.29M | 319.94M | 346.43M | 277.86M | 303.84M | 290.12M |
| Cash & ST investments | 182.64M | 164.95M | 172.65M | 148.05M | 157.63M | 128.75M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 2.07B | 2.09B | 2.11B | 2.04B | 2.08B | 2.07B |
| Total current liabilities | 259.44M | 254.48M | 283.48M | 217.94M | 262.93M | 264.80M |
| Short-term debt | 20.08M | 20.11M | 18.41M | 15.91M | 14.32M | 14.62M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 430,899,000.00 | 424,806,000.00 | 455,860,000.00 | 392,134,000.00 | 443,923,000.00 | 435,278,000.00 |
| Total equity | 1.64B | 1.67B | 1.66B | 1.65B | 1.63B | 1.63B |
| Retained earnings | 225.44M | 236.08M | 241.10M | 255.50M | 265.79M | 283.25M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 46.87M | 202.15M | 142.91M | 180.53M | 126.05M | 117.12M | 169.33M | 198.20M |
| Depreciation & amortization | 54.54M | 104.86M | 109.15M | 103.42M | 63.12M | 57.31M | 44.38M | 48.41M |
| Free cash flow | 19.32M | 163.46M | 96.09M | 131.09M | 82.88M | 80.18M | 128.75M | 153.95M |
| Dividends paid | -27.84M | -46.63M | -55.96M | -59.05M | -59.24M | -58.78M | -58.97M | -57.54M |
| Stock buybacks / issuance | 0 | 0 | 220.00M | -5.91M | -40.12M | -10.00M | -11.51M | -138.89M |
| Ending cash balance | 312.24M | 420.50M | 202.02M | 279.21M | 227.45M | 181.93M | 146.66M | 149.51M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 67.66M | 31.21M | 60.14M | 39.20M | 87.37M | 29.18M |
| Depreciation & amortization | 11.20M | 12.00M | 11.96M | 13.25M | 10.93M | 11.20M |
| Free cash flow | 57.34M | 20.38M | 49.28M | 26.95M | 77.31M | 15.04M |
| Dividends paid | -14.80M | -14.42M | -14.17M | -14.16M | -13.58M | -13.35M |
| Stock buybacks / issuance | -32.03M | -28.01M | -34.28M | -44.58M | -40.00M | -32.75M |
| Ending cash balance | 156.58M | 144.98M | 160.51M | 149.51M | 160.82M | 132.15M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -1.92 | 5.62 | 5.37 | 3.18 | 2.79 | 4.24 | 6.80 | 7.65 |
| ROA %i | -1.58 | 4.70 | 4.22 | 2.39 | 2.09 | 3.26 | 5.40 | 6.19 |
| ROIC %i | -1.91 | 5.37 | 4.79 | 2.70 | 2.37 | 3.71 | 6.17 | 7.15 |
| 5-year avg ROE %i | 26.77 | 13.81 | 8.09 | 4.53 | 3.01 | 4.24 | 4.48 | 4.93 |
| EBIT margin %i | 6.77 | 13.28 | 13.19 | 9.77 | 6.94 | 9.98 | 12.89 | 15.47 |
| FCF / sales %i | 3.05 | 16.39 | 9.35 | 11.58 | 7.78 | 7.08 | 10.55 | 12.14 |
| Current ratioi | 3.36 | 3.34 | 1.43 | 1.88 | 1.57 | 1.57 | 1.41 | 1.27 |
| Quick ratioi | 3.23 | 3.23 | 1.23 | 1.67 | 1.36 | 1.36 | 1.20 | 1.05 |
| Debt / assetsi | 0.14 | 5.91 | 12.32 | 14.37 | 11.99 | 10.04 | 6.11 | 5.35 |
| LT debt / equityi | 0.16 | 5.51 | 14.18 | 17.76 | 14.39 | 11.45 | 6.20 | 5.66 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 13.44 | 31.24 | 31.22 | 21.29 | 2.23 | 3.30 | 2.53 | 5.98 |
| Net income CAGR (3Y) %i | -- | 32.60 | 61.15 | -- | -16.84 | -6.82 | 26.94 | 39.47 |
| FCF CAGR (3Y) %i | -33.21 | 73.38 | 36.11 | 89.32 | -20.26 | -5.86 | -0.60 | 22.92 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 6.86 | 6.89 | 6.76 | 7.65 | 7.91 | 8.15 |
| ROA %i | 5.33 | 5.40 | 5.30 | 6.19 | 6.25 | 6.47 |
| ROIC %i | 6.25 | 6.29 | 6.28 | 7.15 | 7.40 | 7.63 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 13.23 | 13.50 | 14.48 | 15.47 | 15.55 | 15.71 |
| FCF / sales %i | 9.54 | 10.02 | 10.48 | 12.14 | 13.69 | 13.11 |
| Current ratioi | 1.27 | 1.26 | 1.22 | 1.27 | 1.16 | 1.10 |
| Quick ratioi | 1.05 | 1.04 | 1.02 | 1.05 | 0.93 | 0.89 |
| Debt / assetsi | 5.76 | 5.75 | 5.57 | 5.35 | 5.25 | 5.16 |
| LT debt / equityi | 6.05 | 6.01 | 5.99 | 5.66 | 5.81 | 5.64 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- United States (U.S.) Higher Education is the largest reported line at 65.39% of revenue, across 3 reported segments.
- Australia/new Zealand follows at 22.06%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
United States (U.S.) Higher Education65.39%
Australia/new Zealand22.06%
Education Technology Services12.56%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.